CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 74 enrolled
Drug / intervention
eSight Eyeweardevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02616900
NCT02616900N/ACompleted

eQUEST -- ESIGHT QUALITY OF LIFE AND EFFICACY STUDY A Multi-center, Prospective Cohort Study to Assess the Impact of eSight Eyewear on Functional Vision Improvement and Quality of Life in a Low Vision Population

eSight Corporation·interventional·Posted Nov 30, 2015·Updated Apr 5, 2019

In Brief

A clinical study evaluating eSight Eyewear for Vision, Low. Completed, enrolled 74 participants across 6 sites in 2 countries.

Detailed Summary

The "eSight Quality of Life and Efficacy Study" (eQUEST) is a prospective cohort study intended to demonstrate the functional vision and Quality of Life (QoL) improvement provided by eSight Eyewear to persons with significant visual impairment resulting from various eye conditions. The multi-site study will evaluate the efficacy of the eSight device for various Activities of Daily Living (ADLs) across a broad range of subject ages and disease types.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVision, Low
CountriesCanada, United States

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 30, 2015
Enrollment StartDec 16, 2015
Primary CompletionMar 31, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.6 years ago

Interventions

eSight Eyeweardevice

primary intervention